GÖREK DİLEKTAŞLI, A. Et Al. 2014. Feasibility of serum PARC CCL 18 levels in discriminating the frequent exacerbator phenotype a case control study. CHEST 2014 Congress , (Austin, United States Of America).

GÖREK DİLEKTAŞLI, A., DEMİRDÖĞEN ÇETİNOĞLU, E., UZASLAN, A. E., BUDAK, F., URSAVAŞ, A., & EGE, E., (2014). Feasibility of serum PARC CCL 18 levels in discriminating the frequent exacerbator phenotype a case control study . CHEST 2014 Congress, Austin, United States Of America

GÖREK DİLEKTAŞLI, ASLI Et Al. "Feasibility of serum PARC CCL 18 levels in discriminating the frequent exacerbator phenotype a case control study," CHEST 2014 Congress, Austin, United States Of America, 2014

GÖREK DİLEKTAŞLI, ASLI G. Et Al. "Feasibility of serum PARC CCL 18 levels in discriminating the frequent exacerbator phenotype a case control study." CHEST 2014 Congress , Austin, United States Of America, 2014

GÖREK DİLEKTAŞLI, A. Et Al. (2014) . "Feasibility of serum PARC CCL 18 levels in discriminating the frequent exacerbator phenotype a case control study." CHEST 2014 Congress , Austin, United States Of America.

@conferencepaper{conferencepaper, author={ASLI GÖREK DİLEKTAŞLI Et Al. }, title={Feasibility of serum PARC CCL 18 levels in discriminating the frequent exacerbator phenotype a case control study}, congress name={CHEST 2014 Congress}, city={Austin}, country={United States Of America}, year={2014}}